Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical Asia Pacific

Genentech Boosts Singapore Presence With $140 Million Biologics Plant

This article was originally published in The Pink Sheet Daily

  • News

Executive Summary

Lilly also increases R&D efforts in nation with a $150 million expansion.

You may also be interested in...



Merck Opens Asia Pacific Headquarters In Singapore

Merck has opened an Asia Pacific headquarters in Singapore, the firm announced Aug. 21

Merck Opens Asia Pacific Headquarters In Singapore

Firm’s total investment in the country is more than $650 million.

Merck Opens Asia Pacific Headquarters In Singapore

Firm’s total investment in the country is more than $650 million.

Table

View full table

Related Content

Pink Sheet

Topics

Tags:
BioPharmaceutical Asia Pacific
Latest Headlines

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Industry & Regulators To Align Advice on COVID-19 Vaccine Updates

Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines

See All
UsernamePublicRestriction

Register

PS065823

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By